Friday, August 17 , 2018, 4:27 pm | A Few Clouds 76º


Sansum Physician Studies Viagra’s Benefits for Lung Disease

Dr. David Zisman's research is featured in the New England Journal of Medicine

Sansum Clinic Dr. David Zisman’s article “A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis” in the recent New England Journal of Medicine online issue showed that sildenafil — found in Viagra — could lead to reduced shortness of breath and improved quality of life for patients with idiopathic pulmonary fibrosis.

Dr. David Zisman
Dr. David Zisman

Idiopathic pulmonary fibrosis is a lung disease characterized by scarring or thickening of the lungs, with no known cause and no proven therapies to increase life expectancy or improve quality of life.

For patients with this disease, lungs can’t take in sufficient oxygen or expel sufficient carbon dioxide to meet the needs of the cells of the body. Death within five years of the onset of symptoms is characteristic.

The study, called the Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis (STEP-IPF), suggested that sildenafil could lead to reduced shortness of breath and improved quality of life for patients with idiopathic pulmonary fibrosis by widening blood vessels in lung tissue providing for better oxygen and carbon dioxide exchange.

The study was sponsored by the Idiopathic Pulmonary Fibrosis Clinical Research Network of the National Heart, Lung and Blood Institute, and the findings create a significant basis for further medical research.

“To be the lead author of a study published in the most prestigious medical journal in the world is something few leaders in the health-care field achieve,” said Dr. Kurt Ransohoff, CEO, president and medical director of Sansum Clinic. “Dr. Zisman raises the bar for pulmonary care in our community, and it is an honor to have him as a Sansum Clinic physician.”

Click here to view the full NEJM article.

Zisman’s clinical research has included numerous studies of fibrotic lung diseases, idiopathic pulmonary fibrosis and subcutaneous Interferon, among other topics. A renowned expert in idiopathic pulmonary fibrosis, he has lectured nationally and internationally on this and related topics more than 60 times during the past decade. He joined Sansum Clinic’s Department of Pulmonary/Critical Care Medicine in 2009.

— Jill Fonte is the marketing director for the Sansum Clinic.


Support Noozhawk Today

You are an important ally in our mission to deliver clear, objective, high-quality professional news reporting for Santa Barbara, Goleta and the rest of Santa Barbara County. Join the Hawks Club today to help keep Noozhawk soaring.

We offer four membership levels: $5 a month, $10 a month, $25 a month or $1 a week. Payments can be made through Stripe below, or click here for information on recurring credit-card payments and a mailing address for checks.

Thank you for your vital support.

Become a Noozhawk Supporter

First name
Last name
Enter your email
Select your membership level

Payment Information

You are purchasing:

Payment Method

Pay by Credit Card:

Mastercard, Visa, American Express, Discover
One click only, please!

Pay with Apple Pay or Google Pay:

Noozhawk partners with Stripe to provide secure invoicing and payments processing.

  • Ask
  • Vote
  • Investigate
  • Answer

Noozhawk Asks: What’s Your Question?

Welcome to Noozhawk Asks, a new feature in which you ask the questions, you help decide what Noozhawk investigates, and you work with us to find the answers.

Here’s how it works: You share your questions with us in the nearby box. In some cases, we may work with you to find the answers. In others, we may ask you to vote on your top choices to help us narrow the scope. And we’ll be regularly asking you for your feedback on a specific issue or topic.

We also expect to work together with the reader who asked the winning questions to find the answer together. Noozhawk’s objective is to come at questions from a place of curiosity and openness, and we believe a transparent collaboration is the key to achieve it.

The results of our investigation will be published here in this Noozhawk Asks section. Once or twice a month, we plan to do a review of what was asked and answered.

Thanks for asking!

Click Here to Get Started >

Reader Comments

Noozhawk is no longer accepting reader comments on our articles. Click here for the announcement. Readers are instead invited to submit letters to the editor by emailing them to [email protected]. Please provide your full name and community, as well as contact information for verification purposes only.

Daily Noozhawk

Subscribe to Noozhawk's A.M. Report, our free e-Bulletin sent out every day at 4:15 a.m. with Noozhawk's top stories, hand-picked by the editors.

Sign Up Now >